Some of China’s senior doctors are raising concern over the quality of domestic generic medicines that have largely replaced western brand-name drugs at hospitals, amid a rare public backlash against ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

When big pharmaceutical companies merge, the perception is that drug prices rise, but a University of Iowa study finds that’s ...

By John Murphy III Inside Sources As President-elect Donald Trump’s inauguration approaches, pundits and policymakers have debated the effect of potential new and widespread tariffs on products ...

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

The National Healthcare Security Administration said on Monday that it will soon dispatch a team of government officials to ...

The generic drugs are procured from Indian drug makers that are certified by the WHO for following good manufacturing ...

A recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

The generic drugs are procured from Indian drug makers that are certified by the WHO for following good manufacturing ...

As President-elect Donald Trump’s inauguration approaches, pundits and policymakers have debated the effect of potential new ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...